Human papillomavirus: vaccination, related cancer awareness, and risk of transmission among female medical students.

CONCLUSIONS: Female medical students showed low knowledge of HPV vaccination and an extremely low HPV vaccination rate, but a higher level of HPV-related cervical cancer awareness. A substantial number of students were not yet sexually active or had never had sex without a condom. HPV vaccination is thus still important for our respondents. There is an emerging need in educational programs for students starting from their first semester of the program and for a broader informational campaign focused on schoolchildren and their parents. PMID: 31233171 [PubMed - in process]
Source: Acta Dermatovenerologica Alpina, Panonica, et Adriatica - Category: Dermatology Tags: Acta Dermatovenerol Alp Pannonica Adriat Source Type: research

Related Links:

ConclusionsThis is the first large ‐scale randomized clinical trial of HPV vaccination in China. High and sustained vaccine efficacy against HPV‐16/18‐associated infection and cervical lesions was demonstrated up to Month 72. The vaccine had an acceptable safety profile. Combined with screening, prophylactic HPV vaccination cou ld potentially reduce the high burden of HPV infection and cervical cancer in China.Trial registrationNCT00779766.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research
Conclusions Increased HPV vaccination coverage in California is needed to reduce economic and health burdens associated with cancers caused by HPV infection.
Source: Sexually Transmitted Diseases - Category: Sexual Medicine Tags: Original Studies Source Type: research
Conclusions High levels of high-risk HPV infection and type-specific persistence were documented, heightening the urgency of mass role out of HPV vaccination. The association between HPV persistence and HIV transmission is a novel finding, warranting further study.
Source: Sexually Transmitted Diseases - Category: Sexual Medicine Tags: Original Studies Source Type: research
Some 100,000 cases of cancer could be prevented in Britain in the next 40 years by a vaccine against the human papillomavirus (HPV) that causes cancers of the cervix, mouth, anus and genitals, UK health officials said on Tuesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
This study was conducted to determine the size of HPV prevalence in this group and to provide information for future assessment of the impact of vaccine introduction in the country. We conducted a cross-sectional study where the snowballing technique was used to identify and select FSW's ≥18 years, operating within suburbs of Greater Accra Region (GAR). A risk factor assessment interview was conducted and cervical swabs were collected for HPV-DNA detection and genotyping by Nested Multiplex PCR. Hundred participants, age ranging from 18 to 45 years, median 24 years, were studied. The prevalence of Cervical HPV was 26%. ...
Source: Journal of Oncology - Category: Cancer & Oncology Tags: J Oncol Source Type: research
ConclusionsNaturally acquired anti ‐HPV‐16 antibodies were associated with a decreased risk of subsequent infection and cervical abnormalities in women>25  years. This possible protection was lower than that previously reported in 15‐ to 25‐year‐old women.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research
Although human papillomavirus (HPV) strains had previously been described in the literature, the earliest published evidence of the link between HPV and cervical cancer dates to 1983 by Harald zur Hausen and colleagues [1]. Since then, over 200 HPV genotypes have been described [2], and the 2008 Nobel Prize was awarded to zur Hausen for his pioneering work in the field. HPV is a common virus that is efficiently transmitted by sexual exposure and skin-to-skin contact [2]. Certain genotypes of HPV (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68) are categorized as high-risk (HR) due to their causative association...
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Anti-Tumour Treatment Source Type: research
AbstractHuman papillomavirus (HPV) infection is responsible for approximately 5% of all cancers and is associated with 30% of all pathogen-related cancers. Cervical cancer is the third most common cancer in women worldwide; about 70% of cervical cancer cases are caused by the high-risk HPVs (HR HPVs) of genotypes 16 and 18. HPV infection occurs mainly through sexual contact; however, viral transmission via horizontal and vertical pathways is also possible. After HPV infection of basal keratinocytes or ecto-endocervical transition zone cells, viral DNA persists in the episomal form. In most cases, infected cells are elimina...
Source: Biochemistry (Moscow) - Category: Biochemistry Source Type: research
HPV vaccination programs significantly reduce  human papillomavirus infections and precancerous cervical lesions, a new global review finds.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Abstract Objective To evaluate the level of information possessed by pregnant adolescents regarding the human papillomavirus (HPV). Methods Descriptive study developed in the adolescent prenatal outpatient clinic of a tertiary hospital fromthe state of S ão Paulo, Brazil. Data were collected between June and December 2017 following approval from the ethics and research committee (CAAE: 1.887.892/2017). Pregnant adolescents, ≤ 18 years old, who attended the abovementioned outpatient section, composed the sample. Those diagnosed with a psychiatric disorder and those with hearing or cognitive disabilities were exclu...
Source: Revista Brasileira de Ginecologia e Obstetricia - Category: OBGYN Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Dermatology | Education | Genital Warts | Human Papillomavirus (HPV) | Students | Study | Ukraine Health | Universities & Medical Training | Vaccines